{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:32:49Z","timestamp":1787031169591,"version":"build-2736575974"},"reference-count":41,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,8]]},"DOI":"10.4269\/ajtmh.19-0943","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T03:00:27Z","timestamp":1588647627000},"page":"394-403","source":"Crossref","is-referenced-by-count":13,"title":["Cost-Effectiveness Analysis of Sex-Stratified Plasmodium vivax Treatment Strategies Using Available G6PD Diagnostics to Accelerate Access to Radical Cure"],"prefix":"10.4269","volume":"103","author":[{"given":"Angela","family":"Devine","sequence":"first","affiliation":[{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia;"},{"name":"Division of Global and Tropical Health, Menzies School of Health Research, Charles Darwin University, Darwin, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind E.","family":"Howes","sequence":"additional","affiliation":[{"name":"Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom;"},{"name":"Malaria and Fever Programme, Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Price","sequence":"additional","affiliation":[{"name":"Victorian Infectious Diseases Reference Laboratory Epidemiology Unit at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia;"},{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerryn A.","family":"Moore","sequence":"additional","affiliation":[{"name":"Infection and Immunity, Murdoch Children\u2019s Research Institute, Melbourne, Australia;"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Ley","sequence":"additional","affiliation":[{"name":"Division of Global and Tropical Health, Menzies School of Health Research, Charles Darwin University, Darwin, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Simpson","sequence":"additional","affiliation":[{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Dittrich","sequence":"additional","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom;"},{"name":"Malaria and Fever Programme, Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric N.","family":"Price","sequence":"additional","affiliation":[{"name":"Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom;"},{"name":"Division of Global and Tropical Health, Menzies School of Health Research, Charles Darwin University, Darwin, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0140-6736(19)31096-7","article-title":"Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000\u201317: a spatial and temporal modelling study","volume":"394","author":"Battle","year":"2019","journal-title":"Lancet"},{"key":"b2","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/424663","article-title":"Primaquine therapy for malaria","volume":"39","author":"Baird","year":"2004","journal-title":"Clin Infect Dis"},{"key":"b3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12936-018-2380-8","article-title":"Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group","volume":"17","author":"Thriemer","year":"2018","journal-title":"Malar J"},{"key":"b4","doi-asserted-by":"crossref","first-page":"e1002379","DOI":"10.1371\/journal.pmed.1002379","article-title":"Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: a hospital-based cohort study","volume":"14","author":"Douglas","year":"2017","journal-title":"PLoS Med"},{"key":"b5","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(19)31285-1","article-title":"Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial","volume":"394","author":"Taylor","year":"2019","journal-title":"Lancet"},{"key":"b6","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/cid\/ciy319","article-title":"Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria","volume":"67","author":"Chu","year":"2018","journal-title":"Clin Infect Dis"},{"key":"b7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1710775","article-title":"Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria","volume":"380","author":"Lacerda","year":"2019","journal-title":"N Engl J Med"},{"key":"b8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1802537","article-title":"Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria","volume":"380","author":"Llanos-Cuentas","year":"2019","journal-title":"N Engl J Med"},{"key":"b9","doi-asserted-by":"crossref","first-page":"e1001339","DOI":"10.1371\/journal.pmed.1001339","article-title":"G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map","volume":"9","author":"Howes","year":"2012","journal-title":"PLoS Med"},{"key":"b10","volume-title":"Testing for G6PD Deficiency for Safe Use of Primaquine in Radical Cure of P. Vivax and P. Ovale Malaria","year":"2016"},{"key":"b11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1475-2875-12-391","article-title":"G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests","volume":"12","author":"Domingo","year":"2013","journal-title":"Malar J"},{"key":"b12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12936-015-0896-8","article-title":"The challenges of introducing routine G6PD testing into radical cure: a workshop report","volume":"14","author":"Ley","year":"2015","journal-title":"Malar J"},{"key":"b13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12936-018-2248-y","article-title":"Primaquine-induced haemolysis in females heterozygous for G6PD deficiency","volume":"17","author":"Chu","year":"2018","journal-title":"Malar J"},{"key":"b14","volume-title":"Guidelines for the Treatment of Malaria","year":"2015"},{"key":"b15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12936-017-2017-3","article-title":"Methods for the field evaluation of quantitative G6PD diagnostics: a review","volume":"16","author":"Ley","year":"2017","journal-title":"Malar J"},{"key":"b16","doi-asserted-by":"crossref","first-page":"e1002992","DOI":"10.1371\/journal.pmed.1002992","article-title":"Performance of the Access Bio\/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis","volume":"16","author":"Ley","year":"2019","journal-title":"PLoS Med"},{"key":"b17","doi-asserted-by":"crossref","first-page":"e1979","DOI":"10.1371\/journal.pntd.0001979","article-title":"The potential elimination of Plasmodium vivax malaria by relapse treatment: insights from a transmission model and surveillance data from NW India","volume":"7","author":"Roy","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"b18","doi-asserted-by":"crossref","first-page":"e0005602","DOI":"10.1371\/journal.pntd.0005602","article-title":"Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: a cost-effectiveness analysis","volume":"11","author":"Devine","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"b19","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/cid\/ciy235","article-title":"Primaquine pharmacokinetics in lactating women and breastfed infant exposures","volume":"67","author":"Gilder","year":"2018","journal-title":"Clin Infectious Dis"},{"key":"b20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4269\/ajtmh.18-0612","article-title":"Evaluation of a novel quantitative test for glucose-6-phosphate dehydrogenase deficiency: bringing quantitative testing for glucose-6-phosphate dehydrogenase deficiency closer to the patient","volume":"100","author":"Pal","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"b21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMe1816383","article-title":"Tafenoquine\u2013a radical improvement?","volume":"380","author":"White","year":"2019","journal-title":"N Engl J Med"},{"key":"b22","doi-asserted-by":"crossref","first-page":"e1002299","DOI":"10.1371\/journal.pmed.1002299","article-title":"Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: a randomized controlled trial","volume":"14","author":"Abreha","year":"2017","journal-title":"PLoS Med"},{"key":"b23","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4269\/ajtmh.2010.09-0521","article-title":"Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon","volume":"82","author":"Grietens","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"b24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.actatropica.2015.08.008","article-title":"Patients\u2019 adherence and clinical effectiveness of a 14-day course of primaquine when given with a 3-day chloroquine in patients with Plasmodium vivax at the Thai-Myanmar border","volume":"152","author":"Cheoymang","year":"2015","journal-title":"Acta Trop"},{"key":"b25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3329\/jhpn.v27i1.3313","article-title":"Adherence to antimalarial drug therapy among vivax malaria patients in northern Thailand","volume":"27","author":"Khantikul","year":"2009","journal-title":"J Health Popul Nutr"},{"key":"b26","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2471\/BLT.18.226688","article-title":"Provider and household costs of Plasmodium vivax malaria episodes: a multicountry comparative analysis of primary trial data","volume":"97","author":"Devine","year":"2019","journal-title":"Bull World Health Organ"},{"key":"b27","volume-title":"WHO-CHOICE Unit Cost Estimates for Service Delivery","year":"2011"},{"key":"b28","volume-title":"Unit Costs of Health Care Inputs in Low and Middle Income Regions","author":"Mulligan","year":"2005"},{"key":"b29","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0140-6736(12)61680-8","article-title":"Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010","volume":"380","author":"Salomon","year":"2013","journal-title":"Lancet"},{"key":"b30","volume-title":"Life Tables by Country","year":"2016"},{"key":"b31","volume-title":"GDP per Capita (Current US$)","year":"2016"},{"key":"b32","doi-asserted-by":"crossref","first-page":"e000964","DOI":"10.1136\/bmjgh-2018-000964","article-title":"Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data","volume":"3","author":"Ochalek","year":"2018","journal-title":"BMJ Global Health"},{"key":"b33","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/s41467-019-13412-x","article-title":"Resolving the cause of recurrent Plasmodium vivax malaria probabilistically","volume":"10","author":"Taylor","year":"2019","journal-title":"Nat Commun"},{"key":"b34","doi-asserted-by":"crossref","first-page":"e0003595","DOI":"10.1371\/journal.pntd.0003595","article-title":"Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo","volume":"9","author":"Adekunle","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"b35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1475-2875-11-280","article-title":"Primaquine radical cure of Plasmodium vivax: a critical review of the literature","volume":"11","author":"John","year":"2012","journal-title":"Malar J"},{"key":"b36","doi-asserted-by":"crossref","first-page":"e84555","DOI":"10.1371\/journal.pone.0084555","article-title":"How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugs","volume":"9","author":"Bruxvoort","year":"2014","journal-title":"PLoS One"},{"key":"b37","doi-asserted-by":"crossref","first-page":"45963","DOI":"10.1038\/srep45963","article-title":"Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis","volume":"7","author":"Mbanefo","year":"2017","journal-title":"Sci Rep"},{"key":"b38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12936-018-2390-6","article-title":"Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia","volume":"17","author":"Henriques","year":"2018","journal-title":"Malar J"},{"key":"b39","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-020-3123-1","article-title":"Vivax malaria in pregnancy and lactation: a long way to health equity","volume":"19","author":"Brummaier","year":"2020","journal-title":"Malar J"},{"key":"b40","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2012-03-416032","article-title":"Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone","volume":"120","author":"Pamba","year":"2012","journal-title":"Blood"},{"key":"b41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/1475-2875-13-481","article-title":"Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900","volume":"13","author":"Rahimi","year":"2014","journal-title":"Malar J"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T12:37:41Z","timestamp":1611751061000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajtmh.org\/doi\/10.4269\/ajtmh.19-0943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7,8]]}},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.19-0943","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,8]]}}}